ClinicalTrials.Veeva

Menu

The Homburg Keratoconus Center (HKC)

U

Universität des Saarlandes

Status

Enrolling

Conditions

Keratoconus

Treatments

Diagnostic Test: Topographic, tomographic and biomechanical analysis.

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Aim of this study is to conduct longitudinal and cross-sectional analyses about the corneal ectatic disease Keratoconus based on data obtained from Keratoconus patients in the Homburg Keratoconus Center (HKC).

The Homburg Keratoconus Center (HKC) was founded in 2010 and, up to now, comprises more than 3,000 Keratoconus patients. Topographic, tomographic and biomechanic characteristics of the disease are being analyzed with the intention to elucidate how the disease begins and develops during lifetime.

Enrollment

5,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All Keratoconus patients presenting in the department of ophthalmology, Saarland University Medical Center, Homburg, Saarland, Germany.

Exclusion criteria

  • Patients without Keratoconus.

Trial design

5,000 participants in 1 patient group

Patients with Keratoconus
Description:
Aim is to include as many Keratoconus patients as possible with the intention to elucidate how the disease begins and develops during lifetime.
Treatment:
Diagnostic Test: Topographic, tomographic and biomechanical analysis.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems